Quest Diagnostics Incorporated (FRA:QDI)

Market Cap	16.68B
Revenue (ttm)	9.25B
Net Income (ttm)	820.76M
Shares Out	n/a
EPS (ttm)	7.26
PE Ratio	20.33
Forward PE	16.60
Dividend	2.83 (1.86%)
Ex-Dividend Date	Oct 3, 2025

Volume	n/a
Average Volume	17
Open	151.70
Previous Close	153.50
Day's Range	151.70 - 151.70
52-Week Range	139.85 - 168.55
Beta	n/a
RSI	47.47
Earnings Date	Feb 10, 2026

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,...

• Industry: Medical Laboratories
• Founded: 1967
• Employees: 56,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: QDI

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD